BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//swoogo.com//NONSGML kigkonsult.se iCalcreator 2.41.90//
CALSCALE:GREGORIAN
UID:37363933-6437-4162-b434-323330386434
BEGIN:VEVENT
UID:9fbb133264798ffc4c5a0398fbe97257d7dbf459@swoogo.com
DTSTAMP:20260511T025109Z
DESCRIPTION:Substance use disorders are prevalent among people with HIV and
  contribute to poor health outcomes. Substance use may increase the likeli
 hood of risk-taking behaviors\, the potential for drug drug interactions\,
  and the risk or severity of substance-associated toxicities. This session
  will cover the myriad issues a provider should know about best practices 
 for treatment while in corrections and after release\, especially taking i
 nto account continuity of care after reentry. \n\nEducational Objectives\n
 • Summarize screening for substance use disorders in persons with HIV\n• D
 iscuss how substance use disorders contribute to barriers to care for HIV
 \nânâ Describe pharmacologic treatments to address substance use disorders a
 nd the effects on HIV care\n\nEducational session made possible by a medic
 al education grant from Janssen Therapeutics. 
DTSTART:20220802T130000Z
DTEND:20220802T140000Z
LAST-MODIFIED:20260511T025109Z
LOCATION:Centennial A-C Level 3
SEQUENCE:0
STATUS:CONFIRMED
SUMMARY:Plenary Session: HIV and Substance Use Disorders
TRANSP:OPAQUE
X-ALT-DESC;FMTTYPE=text/html:<p>Substance use disorders are prevalent among
  people with HIV and contribute to poor health outcomes. Substance use may
  increase the likelihood of risk-taking behaviors\, the potential for drug
  drug interactions\, and the risk or severity of substance-associated toxi
 cities. This session will cover the myriad issues a provider should know a
 bout best practices for treatment while in corrections and after release\,
  especially taking into account continuity of care after reentry. </p>\n\n
 <p><br />\nEducational Objectives<br />\n- Summarize screening for substan
 ce use disorders in persons with HIV<br />\n- Discuss how substance use di
 sorders contribute to barriers to care for HIV<br />\n- Describe pharmacol
 ogic treatments to address substance use disorders and the effects on HIV 
 care</p>\n\n<p>Educational session made possible by a medical education gr
 ant from Janssen Therapeutics. </p>
BEGIN:VALARM
UID:37363065-6639-4639-a337-633464373761
ACTION:DISPLAY
DESCRIPTION:Substance use disorders are prevalent among people with HIV and
  contribute to poor health outcomes. Substance use may increase the likeli
 hood of risk-taking behaviors\, the potential for drug drug interactions\,
  and the risk or severity of substance-associated toxicities. This session
  will cover the myriad issues a provider should know about best practices 
 for treatment while in corrections and after release\, especially taking i
 nto account continuity of care after reentry. \n\nEducational Objectives\n
 • Summarize screening for substance use disorders in persons with HIV\n• D
 iscuss how substance use disorders contribute to barriers to care for HIV
 \nânâ Describe pharmacologic treatments to address substance use disorders a
 nd the effects on HIV care\n\nEducational session made possible by a medic
 al education grant from Janssen Therapeutics. 
TRIGGER:-PT15M
END:VALARM
END:VEVENT
END:VCALENDAR